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modulates goat monocytes and T cell function in
different patterns
Wang Wang, Shuai Wang, Hui Zhang, Cheng Yuan, RuoFeng Yan, XiaoKai Song, LiXin Xu and XiangRui Li*Abstract
Background: Monocytes and T cells are two major subpopulations of peripheral blood mononuclear cells (PBMC)
and play an essential role in the innate and adaptive immune systems. Different members of the galectin family
show multiple and distinct regulatory effects on different cell types. Previous studies have demonstrated that the
galectin from Haemonchus contortus (Hco-gal-m) performed immunomodulatory effects on goat PBMC, however,
which subpopulation of PBMC is the primary target of Hco-gal-m and whether the immune modulations share the
same mechanism remain unclear.
Methods: In this study, the developmental expression of Hco-gal-m was analyzed by RT-PCR and Western blot
analysis. The distribution of Hco-gal-m in adult worm was detected by an immunohistochemical test. The binding
activity of the recombinant Hco-gal-m (rHco-gal-m) on goat monocytes and T cells were assessed by flow cytometry.
The immunomodulatory effects of Hco-gal-m on cytokine secretion, cell activation and apoptosis were observed by
co-incubation of rHco-gal-m with goat monocytes and T cells.
Results: Hco-gal-m was expressed in L4 as well as adult worms and predominantly localized at the internal surface of
the worm guts. rHco-gal-m could bind to both monocytes and T cells. The engagement of rHco-gal-m decreased the
production of IL-6, IL-10 and TNF-α in T cells, however, it significantly increased the secretion of IL-10 in monocytes.
After rHco-gal-m exposure, the expression of MHC-II on monocytes and that of CD25 on T cells were restricted.
Consequently, T cell proliferations were potently inhibited by rHco-gal-m. In addition, rHco-gal-m induced apoptosis in
T cells, but not significantly in monocytes.
Conclusions: Our results indicated that rHco-gal-m modulated goat monocytes and T cell function in different
patterns.
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Galectins, a family of S-type lectins found in a large scale
of species, are characterized by two features: a specific af-
finity for β-galactoside and a conserved specific sequence
motif called carbohydrate recognition domain (CRD) [1].
To date, 15 mammalian galectins (galectin-1 to -15) have
been cloned and functionally characterized [2], revealing
various roles in apoptosis [3], chemo-attraction [4], cell
adhesion [5], cell proliferation [5], cytokine secretion [6]
and immune responses [7]. After the discovery of the first* Correspondence: lixiangrui@njau.edu.cn
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elegans (C. elegans) [8], similar galectins have also been
isolated from a number of helminth parasites including
H. contortus.
A growing body of experimental evidence indicated that
the parasitic galectins played important roles in the
parasite-host interaction. A recombinant galectin of Tox-
ascaris leonina could enhance the production of TGF-β
and IL-10 in mouse spleen lymphocytes and suppress in-
testinal inflammation [9]. Galectins of T. colubriformis
were shown be recognized by sera from sheep artificially
infected with the nematode [10]. Turner et al. [11,12] re-
ported that galectins extracted from infective larvae (L3td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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tivity to attract eosinophils.
In our previous research, we reported that two isoforms
of galectins, Hco–gal-m (Acc. No. AY253330) and Hco–
gal-f (Acc. No. AY253331), derived, from male (m) and fe-
male (f) H. contortus, respectively [13]. Although, two
galectins are varied by one amino acid in the C-terminal
CRD [14], both rHco–gal-m and rHco–gal-f (rHco-gal-m/f)
can induce the same biological effects and work in the same
way. They inhibited the hemagglutination of goat erythro-
cytes [14], suppressed cytokine mRNA transcription
[15], induced apoptosis of the goat PBMC [16], and
showed partial immunoprotective effects against H. con-
tortus infection [17]. Recently, a combined proteomic
and transcriptomic analysis revealed that the activations
of VEGF pathway, free radical producing pathway,
NFκB pathway and ubiquitin–proteasome pathway in
goat PBMC were down-regulated by rHco-gal-m/f [18].
PBMC is a mixture of subpopulations of function cells,
which includes lymphocytes (T cells, B cells, and NK cells),
monocytes, and dendritic cells [19]. All of the subpopula-
tions are critical to the host responses to pathogen infec-
tions. Monocytes and T cells are two major subpopulations
of PBMC. The best known function of monocytes is as a
considerable systemic reservoir of myeloid precursors for
the renewal of tissue macrophages and other antigen-
presenting cells (APC) [20]. Monocytes are also key effec-
tors of the innate immune response to pathogens and
contribute to recruitment of T-cells at sites of infection
[21]. In turn, the activated T cells assist other white blood
cells in immunologic processes, including maturation of B
cells into plasma cells and memory B cells, and activation
of macrophages. Once activated, T cells divide rapidly and
secrete cytokines that regulate or assist in the active
immune response [22].
It was reported that individual galectins could act on
multiple cell types and induce various biological effects on
different cells [23]. Although we have demonstrated that
Hco-gal-m/f has an important immunomodulatory effect on
goat PBMC, it is still unclear which subpopulation is the pri-
mary target of this immune modulation effect and whether
the immune modulations share the same mechanism.
In the current study, by utilizing rHco-gal-m, we further
explored the unknown biological characteristics of Hco-
gal-m/f and their immunomodulatory effects on goat
monocytes and T cells.
Methods
Ethics statement
The experiment was conducted following the guidelines
of the Animal Ethics Committee, Nanjing Agricultural
University, China. All experimental protocols were ap-
proved by the Science and Technology Agency of Jiangsu
Province. The approval ID is SYXK (SU) 2010-0005.Reagents and antibodies
Ficoll-hypaque was obtained from GE Healthcare (Little
Chalfont, UK). Electrophoresis reagents were from Bio-Rad
(California, USA). RIPA buffer, DAPI and Anti-Fade Fluor-
omount solution were purchased from Beyotime Institute
of Biotechnology (Jiangsu, CHN). Cell culture medium
(RPMI 1640), fetal calf serum (FCS), penicillin and
streptomycin were from Invitrogen. DTT, Tween-20, 2-
mercaptoethanol, phenylmethylsulfonyl fluoride (PSMF),
Triton X-100, lipopolysaccharide (LPS) and Concanav-
alin A (ConA) were purchased from Sigma-Aldrich
(Missouri, USA). Goat Anti-Rat IgG H&L (Alexa Fluor®
647, ab150159) was purchased from Abcam (Massachusetts,
USA). Goat anti-rat IgG-PE (sc-3740) was purchased from
Santa Cruz Biotechnology (California, USA). Monoclonal
antibodies MHC-I (MCA2189A647), MHC-II (MCA2226F)
and isotype controls were purchased from AbD Serotec
(Oxford, UK). CCK-8 was from Dojindo Laboratories
(Kumamoto, JPN).Parasites
H.contortus strain (designated Nanjing 2005) was main-
tained by serial passage in 3-6-month-old, helminth-free
goats [24]. H. contortus eggs were recovered according to
Hubert and Kerboeuf [25]. The faecal sample was sus-
pended in water and cleared of organic debris by filtration
through 1 mm and 150 μm sieves. Eggs were collected on
a 25 μm sieve and further cleared of organic debris by cen-
trifugation in magnesium sulphate (density 1.10 g/cm3)
for five minutes at 1000 × g. The supernatant was filtered
through 100 μm sieves and the eggs were washed in water
and collected on a 25 μm sieve. Faecal cultures from goats
were incubated at 27°C to recover infective third-stage lar-
vae (L3) after 6-7 days [26]. L3 were exsheathed by expos-
ure to 0.2% sodium hypochlorite (NaOCl) bubbled with
air for 30 min at room temperature [27]. Exsheathed L3
(xL3) were separated from cuticular casts by migration
through two 20 μm nylon meshes. xL3 were axenised in
antibiotic solution (0.6 mg/ml penicillin, 1 mg/ml strepto-
mycin, 40 μg/ml gentamycin and 10 μg/ml amphothericin
B), then suspended in RPMI 1640 medium containing
20% (v/v) fetal bovine serum placed in culture flasks
(175 cm2, vented cap, Corning) at a concentration of
1,000-2,000 larvae/ml and incubated at 40°C in 20% CO2
for 7 days to produce early fourth-stage larvae (L4) [27].
The presence of a majority of individuals with L4 stage
mouthparts, as described by Sommerville [28] and Mapes
[29], was confirmed by microscopy. Adult worms were
collected at necropsy from the abomasa of infected donor
goats 28 days after inoculation with 8,000 L3. H.contortus
of each stage were washed extensively in phosphate buff-
ered saline (PBS) several times in order to remove any re-
sidual and subsequently frozen at -70°C for later use.
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the teaching and research flock at Nanjing Agricultural
University were housed indoors in pens containing six
goats per pen. The male goats were fed hay and whole
shelled corn and provided with water ad libitum. All goats
were dewormed twice at 2 week intervals with levamisole
(8 mg/kg bodyweight) orally at the time of housing to
remove naturally acquired strongylid infection. After
2 weeks, a fecal sample from each goat was examined by
microscopy for helminth eggs, according to standard para-
sitological techniques. Goats exhibiting no eggs were used
in the subsequent study and daily health observations
were performed throughout the experiment.
SD rats (body weight ~150 g) were purchased from
the Experimental Animal Center of Jiangsu, PR China
(Qualified Certificate: SCXK 2008-0004) and were raised
in a sterilized room and fed sterilized food and water.
Preparation of rHco-gal-m
The rHco-gal-m was expressed as previously described
[14]. In brief, Total RNA was isolated from H. contortus
adult worms followed by cDNA synthesis. The DNA
fragment encoding for Hco-gal-m was PCR amplified
and cloned into the pBV220 prokaryotic expression vec-
tor. The constructed plasmids were transformed into
Escherichia coli strain DH5α. The cells containing Hco-
gal-m expression plasmid were cultured in Luria-Bertini
medium with ampicillin (100 μg/ml) and induced at 42°C
to express the recombinant proteins.
The purification of rHco-gal-m was conducted by af-
finity chromatography. The cell pellet obtained from one
liter culture was suspended in 100 ml of wash buffer
(10 mM Tris-HCl (pH 7.4) containing 0.5 M NaCl,
5 mM 2-mercaptoethanol, 1 mM EDTA and 1 mM
PSMF) and then sonicated for 15 min on ice. The sonic-
ate was supplemented with 1% (w/v) Triton X-100 and
then stirred for 30 min at 4°C, followed by centrifuga-
tion. The resulting supernatant was added to a lactose-
agarose column (Sigma-Aldrich) and allowed to react
at room temperature for 2 h. The bound fraction was
eluted with 20 mM lactose dissolved in the wash buffer
and then dialyzed against PBS (pH 7.4) containing
0.1 mM DTT (PBS/DTT) (Additional file 1: Figure S1).
LPS was depleted from the rHco-gal-m using Detoxi-
Gel Affinity Pak prepacked columns (Pierce, USA). The
concentrations of the recombinant proteins were equal-
ized to 1 mg/ml prior to LAL assay. Endotoxin levels of
the protein samples were measured by LAL gel clot assay
using a Pyrosate® Kit (Cape Cod Inc., USA). The samples
whose endotoxin content was less than the sensitivity of
the Pyrosate kit (<1EU per 1 mg of the recombinant pro-
teins) were collected for the subsequent experiments. The
E. coli containing empty plasmid were cultured and
the cell lysates were purified under the same conditions.The same volume of purified bacterial lysate (PBL) was
used as the mock control in some experiments.
Generation of polyclonal antibody
Rat polyclonal antibodies against rHco-gal-m were pre-
pared as described previously [18]. Briefly, about 0.3 mg of
the purified rHco-gal-m was mixed with Freund’s complete
adjuvant of a 1:1 mixture and injected into SD rats subcuta-
neously in multiple places followed the method described
by Han et al. [30]. After the first injection, rats were then
boosted four times at 2-week intervals with the same dose.
The serum containing specific anti-rHco-gal-m antibodies
was harvested 10 days following the last injection and then
stored at -70°C for later use.
RT-PCR analysis of Hco-gal-m transcription
To determine whether expression of Hco-gal-m is re-
stricted to specific stages of the parasite’s life-cycle a re-
verse transcriptase PCR (RT-PCR) experiment was carried
out. RNA extraction and preparation of cDNA were per-
formed as previously reported [18]. In brief, total RNA
was isolated from eggs, L3, xL3, L4 and adult worms using
RNeasy Mini Kit (Qiagen, Germany). Then, the RNA
was reverse-transcribed at 52°C for 1 h by Thermo-
Script RT-PCR System (Invitrogen, USA) according to
the standard protocol. The RT-PCR utilized cDNA pre-
pared from different life-cycle stages of H. contortus as
template and specific primers for the complete ORF of
Hco-gal-m (852 bp). The primers were designed by pri-
mer premier software (version 5.0) and were listed as
follows: Hco-gal-Forward (5′-ATGGTGTCACAGTTC
CTACACTGGT-3′) and Hco-gal-Backward (5′-CTAC
TGGATCTGGATGCCAGTCA-3′). The thermal cycle
commenced with a hot start at 94°C for 5 min, followed
by 30 cycles each consisting of 94°C for 60 s, annealing at
55°C for 60 s, and extension at 72°C for 90 s, and termi-
nated after a final 10 min period at 72°C. The products
were separated on a 1.5% agarose gel and visualized by
ethidium bromide staining under UV light.
Western blot analysis of Hco-gal-m expression
Western blot was performed according to the method
reported by Arata et al. [31]. Briefly, samples including
crude somatic extracts of eggs, L3, xL3, L4 and adult
worms were electrophoresed on a 12% SDS-PAGE gel.
Then, the proteins were electro-transferred onto a nitro-
cellulose membrane. After being blocked with 5% (w/v)
skimmed milk powder in PBST (PBS with 0.5% Tween-
20) overnight at 4°C, the membranes were incubated
with the primary antibody against rHco-gal-m (dilutions
1:50) for 1 h at 37°C. The membranes were washed
15 min × 3 with PBST and then incubated with the sec-
ondary antibody goat anti-rat IgG-HRP (Santa Cruz,
USA) in PBST for another 1 h at 37°C. After three
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system (Amersham Biosciences, UK).
Localization of Hco-gal-m by immunohistochemical study
Washed adult worms suspended in PBS were fixed in 4%
formaldehyde-0.2% glutaraldehyde in PBS for 90 min
and then immersed in TISSUE-TeK® O.C.T. compound
(SAKURA, USA). They were snap frozen in liquid nitro-
gen and stored at -20°C until required for further process-
ing. Cryostat sections of 10 μm thickness were cut,
washed with PBS, and treated for 60 min with 10% normal
goat serum in PBS to prevent non-specific binding of anti-
bodies. The sections were then incubated with specific rat
anti-rHco-gal-m antiserum (1:100 dilution) or normal rat
serum (control) for 60 min at 37°C, washed 15 min × 3
with PBS, and subsequently incubated for 60 min with
Goat Anti-Rat IgG H&L Alexa Fluor® 647 (Abcam, UK).
Finally, the sections were stained with DAPI (Beyotime
Institute of Biotechnology, CHN) to show DNA. After
washing with PBS, the specimens were immersed in Anti-
Fade Fluoromount solution (Beyotime Institute of Bio-
technology, CHN), which prevents fading of fluorescence
during microscopic examination.
Isolation of monocytes and T cells
PBMCs were separated from heparinised blood with the
standard Ficoll-hypaque (GE Healthcare, USA) gradient
centrifugation method and washed twice in Ca2+/Mg2+-free
PBS pH 7.4. The PBMCs were resuspended to a final
density of 1 × 106 cells/ml in RPMI 1640 (Invitrogen,
USA) containing 10% heat inactivated fetal calf serum
(FCS), 100 U/ml penicillin and 100 mg/ml streptomycin
(Invitrogen, USA). To obtain monocytes, the PBMCs were
plated in 24-well culture plates and incubated for 2 h at 37°C
in 5% CO2. The non-adherent cells were aspirated and incu-
bated separately under the same conditions for later use.
T cells were isolated from the non-adherent population.
The non-adherent cells were subject to nylon wool
columns (Wako, Japan) as previously described [32,33].
Briefly, the columns were washed and equilibrated with
warm (37°C) complete RPMI. 3 × 108 cells were suspended
in 2 ml of warm complete RPMI, added into the column
and incubated at 37°C for 60 min. The column was eluted
with 20 ml of warm complete RPMI and the T cells were
recollected in a tube. Viability of monocytes and T cells
was > 95% in all the experiments as measured by trypan
blue exclusion test.
Binding of rHco-gal-m to monocytes and T cells
Binding of rHco-gal-m to monocytes and T cells was de-
termined as previously described [34]. Monocytes and T
cells were incubated with 5 μg/ml rHco-gal-m or equal
volumes of control buffer (PBS/DTT) for 1 h at 37°C, re-
spectively. Cells were then incubated with rat anti-rHco-gal-m polyclonal antibody (1:100 dilution) followed by
staining with the secondary antibody goat anti-rat IgG-
PE (Santa Cruz, USA). The binding was quantified using
a flow cytometer (FACSCalibur; BD Biosciences).
Detection of cytokine secretion
To determine cytokine secretion, monocytes and T cells
were stimulated with LPS (100 ng/ml) or ConA (10 μg/ml)
respectively for 72 h in the presence or absence of
rHco-gal-m. The supernatants were collected and cyto-
kine testing was performed by ELISA. Based on the
known cross-reactivity with goat cytokines [35,36], the
concentrations of TNF-α, IL-6 and IL-10 were assessed
with the following commercially available ELISA kits:
Bovine TNF-α duo set (R&D System, UK); Bovine IL-6
ELISA kits (Thermo Scientific, USA) and Bovine Inter-
leukin 10 (Cusabio Biotech Co., LTD.).
Analysis of MHC molecule expression
The purified monocytes (0.5 × 106 cells/ml) were incu-
bated with different concentrations of rHco-gal-m or
equal volumes of control buffer for 24 h in complete
RPMI 1640 at 37°C. Cells were then stained with the
monoclonal antibodies to MHC-I (MCA2189A647) and
MHC-II (MCA2226F), and analyzed on a FACS Calibur
cytometer (BD Biosciences). Results were expressed as
the percentage of mean fluorescence intensity (MFI) of
control.
Cell proliferation assays
T cells (1 × 106 cells/ml) were activated with ConA
(10 μg/ml) and incubated at the same time with a serial
concentrations of rHco-gal-m or equal volume of con-
trol buffer at 37°C and 5% CO2 for 72 h. CCK-8 solu-
tions (Dojindo, Japan) were added to each well of the
plates 4 h before harvesting and the absorbance values
at 450 nm (OD450) were measured using a microplate
reader (Thermo Scientific, USA). Cells exposed to
ConA with control buffer served as controls and the
OD450 in controls were set as 100%. Cell proliferation
index was calculated by the formula: OD450 rHco-gal-
m /OD450 control.
Real-time PCR analysis of the marker genes
T cells were activated with ConA (10 μg/ml) and simul-
taneously treated with rHco-gal-m (20 μg/ml) or equal
volumes of control buffer at 37°C and 5% CO2 for 24 h.
The expression of CD25, CCNA1, CCNB1 and CCND1
was analyzed by real-time PCR. RNA extraction and
preparation of cDNA were performed as previously re-
ported [18]. Real-time PCR was conducted on the ABI
7500 Real-Time PCR System (Applied Biosystems, USA),
using standard procedure (Stage 1: Initial denaturation,
95°C for 30 s, 1 cycle; Stage 2: Amplification, 95°C for 5 s,
Table 1 Primer sequences of target genes in real-time PCR assay
Gene GenBank Forward primer Reverse primer Amplicon
Name Accession 5′→ 3′ 5′→ 3′ Size (bp)
CD25 NM_174358 AGATGTCCTGGCTTGAAC TGGATATAGACCTGCTAATACC 134
CCNA1 XM_005687507 CGCCACATTTACAGGCTATTCATT GTACTTCTCCCTGATTGCTTGCTG 112
CCNB1 XM_005694606 TTGATGGAACTGACTATGCTGGACT CAGGTAATGCTGTAGAGTTGGTGTC 132
CCND1 XM_005700049 AGGAGGTGAGGGTGGAAGTGTG GAAGTCATCGGTAGCAGCGAATAA 100
GAPDH DQ152956 CCTGGAGAAACCTGCCAAGT GCCAAATTCATTGTCGTACCA 200
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ramp rate 1%). Each reaction was performed in a total vol-
ume of 20 μl containing 1× SYBR® Premix Ex Taq
(TaKaRa, Japan), 500 nM of each primer and a constant
amount of cDNA (corresponding to 20 ng of reverse tran-
scribed RNA for each sample). To ensure cDNA samples
were not contaminated with genomic DNA, reactions
were set up using 20 ng of non-reverse transcribed RNA
in place of cDNA. Failure to generate a detectable signal
signified the sample as DNA free. Negative (no template)
controls were included in each PCR run. Melt curves were
generated to ensure a single amplicon had been produced.
Primers specific for target goat genes were designed with
Beacon Designer 7.0 software (Premier Biosoft Inter-
national, USA) according to manufacturer’s guidelines and
the efficiency of each primer set was verified by running
standard curves in triplicates using serial dilutions of the
cDNA (Table 1). The amplification efficiency was calcu-
lated from the slope of the standard curve by the for-
mula: E = 10-1/slope for each run and ranged between
90% and 110%. Target gene expression was normalized
to GAPDH, using the 7500 software version 2.0.6 (Ap-
plied Biosystems, USA). T cells exposed to ConA with
control buffer were selected as the reference sample
and the relative mRNA expression levels of target
genes in rHco-gal-m treated T cells were calculated
using the 2−ΔΔCt method [37]. Each experiment was
tested in triplicate.Apoptosis assay
Cell apoptosis was analyzed as previously described using a
flow cytometer [16]. In brief, monocytes and T cells were
cultured for 24 h in the presence or absence of rHco-gal-m
at different concentrations followed by staining with
annexin V and PI (eBioscience, USA) according to the man-
ufacturer’s instructions.Figure 1 The timing and site of Hco-gal-m expression.
Typically, the onset of expression of Hco-gal-m is associated with
the fourth larval stage and continues in the adults, which were
analyzed by RT-PCR (A) and western blot (B). M, DL2000 marker;
1, eggs; 2, L3; 3, exsheathed L3; 4, L4; 5, day 28 adults.Statistical analysis
Data are expressed as mean ± the standard deviation of
the mean. Statistical analysis for significant differences was
performed using an analysis of variance, the Student’s
t test for parametric samples (GraphPad Prism, USA).Results
Developmental regulation of Hco-gal-m expression
RT-PCR analysis showed that there was no significant
transcription in eggs and L3, but that a high-steady level
of transcription was detected from L4 to adult parasites
(Figure 1A). In addition, a similar result was also observed
on protein level, which was analyzed by western blot using
rat antiserum eluted from rHco-gal-m (Figure 1B).
Immunolocalization of Hco-gal-m
A section through a partial body length of an adult female
worm was shown in Figure 2. Hco-gal-m and DNA fluo-
resced red and blue, respectively. Clusters of blue spots
observed inside the adult indicating the position of cell
nuclei were mainly cross-sections of eggs. The antibody
eluted from rHco-gal-m bound predominantly to the
Figure 2 Immunohistochemical localization of Hco-gal-m protein in cryostal section of H. contortus. Hco-gal-m protein was detected by
the indirect immunofluorescence method using second antibody Goat Anti-Rat IgG H&L (Alexa Fluor® 647). The section was counterstained with
DAPI to show DNA. (A) Hco-gal-m is localized in the luminal surface of the adult worm’s gut. (B) No labeling was observed in negative control.
The arrow indicates the gut brush border. Original magnifications: ×400.
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beling was observed in control experiments (Figure 2B).
Binding of rHco-gal-m to monocytes and T cells
Goat monocytes and T cells were isolated and incubated
with rHco-gal-m. The binding of rHco-gal-m to the cells
was quantified by flow cytometric analysis. As depicted in
Figure 3, rHco-gal-m could bind strongly to both mono-
cytes (Figure 3A) and T cells (Figure 3B).Figure 3 Binding of rHco-gal-m to monocytes and T cells. Flow cytom
and T cells (B) using rHco-gal-m detected by rat anti-rHco-gal-m antibody
three individual experiments.Distinct cytokine secretion of monocytes and T cells
induced by rHco-gal-m
By performing ELISA we noted that rHco-gal-m de-
creased the production of TNF-α in both monocytes and
T cells (Figure 4). Interestingly, the secretion of IL-10 was
increased in monocytes (Figure 4A) but dramatically
inhibited by rHco-gal-m in T cells (Figure 4B). In T cells,
rHco-gal-m potently reduced IL-6 (Figure 4B), however, it
failed to be significant for IL-6 in monocytes (Figure 4A).etric analysis of rHco-gal-m binding to goat peripheral monocytes (A)
and PE-labeled secondary antibody. The data are representative of
Figure 4 Distinctive modulation of cytokine secretion by rHco-gal-m. Monocytes (A) and T cells (B) were stimulated with LPS (100 ng/ml) or
ConA (10 μg/ml) respectively for 72 h in the presence or absence of rHco-gal-m. Cytokine secretion in the supernatant of cell cultures was
quantified by ELISA. The data are representative of three independent experiments (**p < 0.01).
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Compared to the baseline expression of MHC-II in the
control buffer, rHco-gal-m significantly decreased MHC-II
expression in a dose-dependent manner (Figure 5A,B).
However, no changes were detected in MHC-I following
exposure of goat monocytes to rHco-gal-m at different
concentrations (Figure 5C,D).
rHco-gal-m inhibited T cells activation and proliferation
As demonstrated by incorporation of CCK-8, rHco-gal-m
significantly inhibited the proliferation of T cells in vitro
(Figure 6A). This inhibitory effect was further supported
by the expression of some marker genes. Real-time PCR
analyses proved that, rHco-gal-m significantly inhibitedthe transcription of CD25, a sensitive marker for T cell ac-
tivation, and the cell cycle genes, CCNA1 (cyclin A1) and
CCND1 (cyclin D1) (Figure 6B).rHco-gal-m induced apoptosis of T cells but not monocytes
Using the externalization of membrane phosphaidylser-
ine (PS) as a marker of cell apoptosis and positive DNA
staining as an indicator for membrane leakage, it was
observed that there was no significant change in annexin
V positive monocytes when treated with control buffer
or increasing concentrations of rHco-gal-m (Figure 7A).
On the contrary, rHco-gal-m induced T cell apoptosis in
a dose-dependent manner (Figure 7B).
Figure 5 rHco-gal-m inhibits MHC-II expression on goat monocytes. Monocytes were cultured in the presence of control buffer (PBS/DTT) or
different concentrations of rHco-gal-m for 24 h. MHC-II expression was measured by flow cytometric analysis and calculated as the percentage of
mean flourscence intensity (MFI) of controls. Histograms (A/C) correspond to 1 representative of three independent experiments, and nonspecific
binding was determined using a control isotype antibody (filled histogram). Bars (B/D) represent the MFI ± SD of controls. The data are representative
of three independent experiments (*p < 0.05).
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Hco-gal-m has a tandem repeat structure. Its predicted
amino acid sequence shows a high degree of identity
with Hco-gal-3b [13] as well as mammalian galectin-4
(Additional file 2: Table S1). In the whole life cycle
stages of H. contortus, there is no detectable expression
of Hco-gal-m in eggs or L3. However, this galectin is
expressed in L4 and adults, the more mature stages of
the parasite’s life-cycle (Figure 1). The expression coin-
cided with the onset of blood feeding, suggesting that its
major role was in the adult parasite, such as develop-
ment and (or) immune evasion.
Mammalian galectins have been detected in many
types of cells and tissue, however, the digestive tract is
particularly rich in galectins [38]. Similar to its mamma-
lian homologues, we demonstrated that the native Hco-
gal-m protein was predominantly covering the worm’s
gut internal surface (Figure 2). In C. elegans, a 32 kDa
galectin was found to be localized most abundantly inthe adult cuticle and the terminal bulb of the pharynx
[31]. Hco-GAL-2, a galectin of H. contortus, was found
to be present on the intestinal brush-border [39].
Proteomic analysis of excretory/secretory (ES) proteins
indicated galectins were expressed numerously in H.
contortus, Ostertagia ostertagi and Teladorsagia cir-
cumcincta [40]. Recently, we found that rHco-gal-m/f
could be recognized by the antiserum from goats ex-
perimentally infected with H. contortus and interacted
with goat PBMC in vitro [18]. All of these results indi-
cated that galectins of H. contortus were excretory/
secretory antigens and interacted with the host im-
mune system during infection. Theoretically, the im-
munomodulatory functions proposed require constant
secretion and certain concentrations of this molecule.
However, how Hco-gal-m accumulates to the func-
tional concentration in vivo and the real mechanism
through which it works during natural infection of
H. contortus should be further studied.
Figure 6 Inhibitory effect of rHco-gal-m on T cell activation and
proliferation. (A) T cells were activated with ConA and incubated
at the same time with serial concentrations of rHco-gal-m at 37°C
and 5% CO2. The proliferation was measured by CCK-8 incorporation
after 72 h. Cell proliferation index was calculated considering the
OD450 values in controls as 100%. (B) T cells were simultaneously
treated with ConA and rHco-gal-m at 37°C and 5% CO2 for 24 h.
The expression of CD25, CCNA1, CCNB1 and CCND1 was analyzed
by real-time PCR. All experiments were set up in triplicate. The
data are representative of three independent experiments
(*p < 0.05 and **p < 0.01).
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sion during the parasite infection and have therefore
been considered as key players in parasite-host interac-
tions [11,41]. In this study, rHco-gal-m bound strongly
to goat monocytes as well as T cells (Figure 3), and this
binding may trigger a cascade of transmembrane signal-
ing events in different biological processes such as acti-
vation and homeostasis of host immune cells [2].
Cytokine secretion is a major role of immune cells, en-
abling communication as well as regulation of the immune
system. In a previous study, we found that the activations
of VEGF pathway, free radical producing pathway, NFκB
pathway and ubiquitin–proteasome pathway in goat
PBMC were down-regulated [18] and the cytokine tran-
scription in goat PBMC was inhibited by rHco-gal-m/f
[15]. In the present research, rHco-gal-m decreased IL-6,
IL-10 and TNF-α secretion in T cells (Figure 4B), butincreased the secretion of IL-10 and inhibited the produc-
tion of TNF-α in monocytes (Figure 4A). These results ob-
viously suggested that rHco-gal-m induced a distinct
cytokine secretion pattern in monocytes and T cells and
highlighted the multiple and distinct biological effects of
galectins on different cell types.
MHC-II molecules are constitutively expressed on the
surface of APCs, enabling them to present extracellular
antigens and initiate the adaptive immune response [42].
Activation of APCs increases MHC-II expression [43].
Barrionuevo et al. [44] reported that galectin-1 inhibited
constitutive and inducible MHC-II expression on human
monocytes and interfered with MHC-II-dependent anti-
gen presentation. Recently, it was reported that galectins
prevented Salmonella-induced MHC-II up-regulation
and modulated APC activation [45]. In the present
study, we noted that rHco-gal-m was able to inhibit
MHC-II expression on monocytes in a dose dependent
manner (Figure 5). This may due to the “deactivation” of
monocytes triggered by high amounts of IL-10 [46]. But,
the real mechanisms need further investigations. The
main function of MHC-I is to display intracellular pro-
teins to cytotoxic T cells [47]. No significant change of
MHC-I expression was observed after exposure of rHco-
gal-m in the present study. It might be that H. Contortus
is a kind of extracellular parasite and Hco-gal-m does
not affect the endogenous antigen presentation pathway.
However, further studies are required to identify the ac-
tual mechanisms responsible.
In this study, incorporation of rHco-gal-m significantly
inhibited mitogen-induced activation and proliferation
in T cells (Figure 6). T cell activation, cytokine secretion
and cell cycling, a complexly regulated movement, was
ultimately linked [48]. Cyclin A1 and cyclin D1, encoded
by the CCNA1 and CCND1 gene, regulate the S-phase
and promote the G1/S transition [49]. Cyclin B1 is
encoded by the CCNB1 gene and contributes to the G2/
M transition [50]. In this study, the transcription of
CCNA1 and CCND1 were decreased (Figure 6B). This
suggested that a block in the cell cycle at the G1 phase
was induced by rHco-gal-m.
It was reported that rHco-gal-m/f could induce apop-
tosis of PBMC of goat [16]. In our study, we revealed
that goat T cells showed significantly higher susceptibil-
ity to rHco-gal-m-induced apoptosis than monocytes
(Figure 7), adding more evidence to the fact that differ-
ent immune cell types can display different phenotypes
following exposure to galectins [51-54]. It also indicated
that the induction of T cell apoptosis, together with the
inhibition of T cell proliferation identified in this study
might be one of the mechanisms of H. contortus to es-
cape host immune responses.
However, many types of galectins have been reported
up to now. But the influence they exert on goat immune
Figure 7 rHco-gal-m distinctively influences the survival of goat monocytes and T cells. Goat monocytes and T cells were cultured in the
presence of control buffer (PBS/DTT) or different concentrations of rHco-gal-m for 24 h. Apoptosis of monocytes (A) and T cells (B) was
determined by staining with annexin V and PI followed by flow cytometric analysis. Data are representative of three individual experiments.
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fects of galectin on goat monocytes and T cells. Whether
the immunomodulatory properties described here are a
specific property of rHco-gal-m or a generic property of
parasitic nematode galectins still needs further research.
Conclusion
In this study, we analyzed the timing and site of Hco-
gal-m expression in H. contortus and demonstrated that
rHco-gal-m could bind to monocytes as well as T cells,
and therefore modulated their activation, cytokine pro-
duction and apoptosis in different patterns. This result
provides more evidence in support of the fact that Hco-
gal-m is one of the host immunomodulation related
molecules and plays an important role in host-parasite
interactions. Our study provides a better understanding
of the role of this parasitic galectin within the host im-
mune system. However, the specific receptors on the cell
surface and the different mechanisms through which
rHco-gal-m modulates cytokine secretion, MHC expres-
sion and cell apoptosis of T cells and monocytes remain
unclear and further studies are required.Additional files
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